Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
All three major U.S. benchmarks finished the session at new closing highs for 2026, signaling broad market strength a...
Berkshire Hathaway underperforming vs the S&P 500 in 2026, even as Warren Buffett’s top holdings rise. A look at why ...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Howard Marks cautions that the AI stock rally may be more speculation than solid analysis, urging investors to anchor...
Target stock continues disappoint as the retailer unveils a growth plan amid slowing sales and mounting questions on ...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
Wealthy family offices are reassessing multi-generational real estate bets as the market shifts and the Great Wealth ...
AT&T's AI-driven customer app sparked a notable move in the stock market today, march, as investors weigh tech-enable...
A fresh rally in semiconductor names has investors buzzing about CPU pricing power and AI infrastructure demand. This...
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
As major indices retreat in March, traders question whether Trump losing grip market? influence is waning. Volatility...